Trial · NCT01013532
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to the first occurrence of cerebral hemorrhage | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Primary | Time to the first occurence of composite cardiovascular events | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Secondary | Time to the first occurrence of stroke | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Secondary | Time to the first occurrence of ischemic stroke | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Secondary | Time to the first occurence of myocardial infarction | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Secondary | Time to the first occurence of other designated vascular events | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Other | Incidence rate of major and non-major hemorrhagic event | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Other | Rate of asymptomatic hemorrhage in GRE (microhemorrhage or macrohemorrhage) | at final visit, follow-up MRI will be checked at the final visit | |
| Other | Rate of new asymptomatic cerebral infarction lesion in FLAIR | at final visit, follow-up MRI will be checked at the final visit | |
| Other | Change of ankle-brachial index | at final visit;follow-up period is 1.0 to 5.5 years | |
| Other | The effect of the size of common carotid artery(CCA) including plaque on the occurrence of cardiovascular events | at final visit;follow-up period is 1.0 to 5.5 years | |
| Other | Time to all deaths including vascular and non-vascular deaths | time since randomization; follow-up period is 1.0 to 5.5 years | |
| Other | Incidence rate of dementia diagnosed after initiation of the trial | time since randomization; follow-up period is 1.0 to 5.5 years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01013532/registered